Zuraiz Chaudhary insider trades: Turn Therapeutics (TTRX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Zuraiz reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | TTRX | ↑ Buy | 2,500 | $3.50 | $9K | Direct | Dec 12, 2025 (0d) |
| Nov 21, 2025 | TTRX | ↑ Buy | 2,450 | $2.89 | $7K | Direct | Nov 21, 2025 (0d) |
| Nov 17, 2025 | TTRX | ↑ Buy | 2,500 | $3.62 | $9K | Direct | Nov 17, 2025 (0d) |
| Oct 23, 2025 | TTRX | ↑ Buy | 5,050 | $4.95 | $25K | Direct | Oct 23, 2025 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TTRX insiders
Open-market trades in the last 12 months
About Zuraiz Chaudhary's insider trades
Zuraiz Chaudhary is See Remarks at Turn Therapeutics (TTRX). Since Oct 23, 2025, Zuraiz has reported 4 open-market purchases worth $50K and no sales on SEC Form 4. In the last 12 months: 3 buys ($25K).
Their filings also include grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TTRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.